After Hours
$
662.89
Change
+1.75 +0.26%
Volume
Volume 40,395
May 20, 2022, 6:54 p.m.
Quotes are delayed by 20 min
Today's close
$ 657.15
$ 661.14
Change
+3.99 +0.61%
Day low
Day high
$647.54
$664.90

52 week low
52 week high
$492.13
$747.42

Market cap
$72.19B
Average volume
669,026
P/E ratio
9.37
Rev. per Employee
$1.59M
EPS
70.60
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on REGN
-
Sanofi Receives Another Approval for Blockbuster Drug Dupixent
- Barron's Online
-
Regeneron Pharmaceuticals Inc. stock rises Friday, outperforms market
- MarketWatch Automation
-
Regeneron Pharmaceuticals Inc. stock outperforms market despite losses on the day
- MarketWatch Automation
-
Regeneron Pharmaceuticals Inc. stock falls Wednesday, still outperforms market
- MarketWatch Automation
-
Regeneron Pharmaceuticals Inc. stock rises Tuesday, still underperforms market
- MarketWatch Automation
-
Regeneron Pharmaceuticals Inc. stock rises Monday, outperforms market
- MarketWatch Automation
-
Regeneron Pharmaceuticals Inc. stock rises Friday, still underperforms market
- MarketWatch Automation
-
Regeneron Pharmaceuticals Inc. stock outperforms market on strong trading day
- MarketWatch Automation
-
Regeneron Pharmaceuticals Inc. stock falls Wednesday, still outperforms market
- MarketWatch Automation
-
Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day
- MarketWatch Automation
-
Regeneron Pharmaceuticals Inc. stock falls Monday, underperforms market
- MarketWatch Automation
-
Regeneron Pharmaceuticals Inc. stock underperforms Friday when compared to competitors
- MarketWatch Automation
-
Regeneron Pharmaceuticals Inc. stock outperforms market despite losses on the day
- MarketWatch Automation
-
Regeneron Pharmaceuticals Inc. stock rises Wednesday, still underperforms market
- MarketWatch Automation
-
Regeneron First-Quarter Earnings Top Forecasts
- Barron's Online
-
Regeneron shares up 1.4% premarket after earnings top estimates
- Ciara Linnane
-
Regeneron shares up 1.4% premarket
- Ciara Linnane
-
Regeneron Q1 EPS $8.61 vs. $10.09 a year ago
- Ciara Linnane
-
Regeneron Q1 adj. EPS $11.49; FactSet consensus $9.68
- Ciara Linnane
-
Regeneron Q1 revenue $2.965 bln vs. $2.529 bln a year ago; FactSet consensus $2.690 bln
- Ciara Linnane
- Loading more headlines...
Analyst Ratings
Other News on REGN
-
Galapagos: Can The Company Turn Around?
- Seeking Alpha
-
Krensavage Asset Management, LLC Buys 2, Sells 3 in 1st Quarter
- GuruFocus.com
-
PUTNAM INVESTMENTS LLC Buys 1, Sells 4 in 1st Quarter
- GuruFocus.com
-
The Correction In Biopharmaceutical Stocks Is Likely Over
- Seeking Alpha
-
My 'Do Nothing Club' Returned 68% in the Past Year
- GuruFocus.com
-
Top 5 1st Quarter Trades of Dodge & Cox
- GuruFocus.com
-
Hideout In Healthcare? Here Are Our Top 3 Ideas
- Seeking Alpha
- Loading more headlines...
Press Releases on REGN
-
Antibody Cocktail Market Key Manufacturers and Industry Demand Analysis to 2030
- Market Insight Reports
-
Regeneron Pharmaceuticals REGN Pivots Trading Plans and Risk Controls
- Stock Traders Daily
-
When Regeneron Pharmaceuticals (REGN) Moves Investors should Listen
- Stock Traders Daily
-
Regeneron Reports First Quarter 2022 Financial and Operating Results
- PR Newswire - PRF
-
Regeneron Announces Investor Conference Presentations
- PR Newswire - PRF
-
Trend Tracker for Regeneron Pharmaceuticals REGN
- Stock Traders Daily
-
Regeneron Pharmaceuticals REGN Trading Signals
- Stock Traders Daily
-
SHAREHOLDER ALERT: Weiss Law Investigates Checkmate Pharmaceuticals, Inc.
- PR Newswire - PRF
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com